http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2481890-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c539db959cc0106cab1662303f94fce
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-711
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J3-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-711
filingDate 2003-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e5aef875bd79b0b8bf7bbc113ce74a9
publicationDate 2004-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2481890-A1
titleOfInvention Synergistic interaction of abacavir and alovudine
abstract A pharmaceutical preparation comprising a synergistic combination of abacavi r and alovudine and a pharmaceutical carrier therefor. Use of abacavir and alovudine together for the treatment of multiresistant HIV, wherein the use comprises simultaneous, combined or sequential administration of alovudine a nd abacavir.
priorityDate 2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409028757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534595
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID131536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502998
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135433604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410129964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497609
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID35370
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33039
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540091
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398739

Total number of triples: 55.